Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
Kalincik, Tomas, Brown, J William L, Robertson, Neil, Willis, Mark, Scolding, Neil, Rice, Claire M, Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael, McGuigan, Christopher, JokubТом:
16
Мова:
english
Журнал:
The Lancet Neurology
DOI:
10.1016/S1474-4422(17)30007-8
Date:
April, 2017
Файл:
PDF, 469 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
